Clene Inc. Warrant (CLNNW) Financials

CLNNW

FY2025 annual

Revenue $200K -41.5% YoY

Net Income -$26.2M +33.6% YoY

Free Cash Flow -$18.6M +12.9% YoY

Operating Cash Flow -$18.5M +13.0% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 14, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CLNNW SEC filings page.

Clene Inc. Warrant (CLNNW) reported $200K in revenue for fiscal year 2025, down 41.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CLNNW FY2025 2026-08-30

Clene operates as a development-stage business: modest commercial revenue is dwarfed by research spending and operating cash consumption.

In FY2025, $14.0M of R&D was many times $200K of revenue, indicating a development-funded commercialization model rather than a revenue-funded operation. Free cash flow of -$18.6M nearly matched operating cash flow of -$18.5M, showing that cash use is driven mainly by ongoing development, not heavy capital investment.

Assets fell from $52.3M in FY2023 to $18.1M in FY2025 even as liabilities stayed broadly stable, shifting the financing burden away from equity. Equity was negative -$17.6M in FY2025, and the 0.8x current ratio indicates current assets did not fully cover current liabilities.

Operating cash flow improved from -$30.2M in FY2023 to -$18.5M in FY2025, but remained negative. R&D also declined from $26.7M to $14.0M, so the smaller cash deficit appears partly linked to reduced development spending rather than self-funded operations.

Financial Health Signals

Financial health score not available

Clene Inc. Warrant does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

1/8

Clene Inc. Warrant passes 1 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

Clene Inc. Warrant reported a net loss of $26.2M while operations used $18.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Clene Inc. Warrant reported an operating loss of $23.1M against $2.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$15K

YoY-81.5%

QoQ-80.5%

5Y CAGR-41.2%

Clene Inc. Warrant generated $15K in revenue in Q1 2026. This represents a decrease of 81.5% from the same quarter a year earlier. Against the prior quarter it is down 80.5%.

EBITDA

-$1.7M

YoY+53.5%

QoQ+76.1%

Clene Inc. Warrant's EBITDA was -$1.7M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 53.5% from the same quarter a year earlier. Against the prior quarter it is up 76.1%.

Net Income

-$8.1M

YoY-977.4%

QoQ+12.3%

Clene Inc. Warrant reported -$8.1M in net income in Q1 2026. This represents a decrease of 977.4% from the same quarter a year earlier. Against the prior quarter it is up 12.3%.

EPS (Diluted)

Not reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt

$5.9M

YoY-39.6%

QoQ+14.5%

5Y CAGR-34.2%

Clene Inc. Warrant held $5.9M in cash against $17.7M in long-term debt as of Q1 2026.

Shares Outstanding

12M

YoY+37.2%

QoQ+8.6%

5Y CAGR-27.7%

Clene Inc. Warrant had 12M shares outstanding in Q1 2026. This represents an increase of 37.2% from the same quarter a year earlier. Against the prior quarter it is up 8.6%.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin

100.0%

YoY+24.7pp

QoQ+29.9pp

Clene Inc. Warrant's gross margin was 100.0% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 24.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 29.9 percentage points.

Operating Margin

Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for Q1 2026.

Capital Allocation

R&D Spending

$329K

YoY-77.8%

QoQ-94.0%

5Y CAGR-44.5%

Clene Inc. Warrant invested $329K in research and development in Q1 2026. This represents a decrease of 77.8% from the same quarter a year earlier. Against the prior quarter it is down 94.0%.

Share Buybacks

Not reported for Q1 2026.

Capital Expenditures

Not reported for Q1 2026.

CLNNW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CLNNW quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19
Revenue	$134K	$200K-41.5%	$342K-47.7%	$654K+38.3%	$473K-34.6%	$723K+251.0%	$206K	N/A
Cost of Revenue	$23K	$43K-38.6%	$70K-42.1%	$121K+365.4%	$26K-91.0%	$289K	N/A	N/A
Gross Profit	$111K	$157K-42.3%	$272K-49.0%	$533K+19.2%	$447K+3.0%	$434K	N/A	N/A
R&D Expenses	$12.9M	$14.0M-30.1%	$20.1M-24.7%	$26.7M-16.5%	$31.9M+12.3%	$28.4M+86.9%	$15.2M+59.0%	$9.6M
SG&A Expenses	$8.3M	$9.2M-30.6%	$13.3M-7.7%	$14.4M-14.9%	$16.9M-23.0%	$22.0M+327.0%	$5.2M-23.9%	$6.8M
Operating Income	-$21.1M	-$23.1M+30.2%	-$33.1M+18.4%	-$40.5M+16.3%	-$48.4M+3.1%	-$50.0M-147.2%	-$20.2M-23.8%	-$16.3M
EBITDA	N/A	-$21.6M+31.2%	-$31.4M+19.0%	-$38.7M+18.1%	-$47.3M+3.3%	-$48.9M-156.6%	-$19.1M-24.7%	-$15.3M
Interest Expense	$2.9M	$2.7M-34.0%	$4.1M-10.8%	$4.6M+38.3%	$3.3M+278.9%	$870K-8.4%	$950K+979.5%	$88K
Income Tax	$0	$0	$0	$0	$0+100.0%	-$428K-205.4%	$406K	N/A
Net Income	-$33.5M	-$26.2M+33.6%	-$39.4M+20.4%	-$49.5M-65.5%	-$29.9M-207.2%	-$9.7M+49.5%	-$19.3M-19.3%	-$16.2M
EPS (Basic)	N/A	-$2.65+53.3%	-$5.67+39.9%	-$9.43-1950.0%	-$0.46-187.5%	-$0.16	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$15K-81.5%	$77K-15.4%	$15K-82.8%	$27K-70.3%	$81K+11.0%	$91K-46.5%	$87K-19.4%	$91K-66.2%
Cost of Revenue	$0-100.0%	$23K+27.8%	$0-100.0%	$0-100.0%	$20K+25.0%	$18K-52.6%	$18K+50.0%	$18K-72.7%
Gross Profit	$15K-75.4%	$54K-26.0%	$15K-78.3%	$27K-63.0%	$61K+7.0%	$73K-44.7%	$69K-28.1%	$73K-64.0%
R&D Expenses	$329K-77.8%	$5.5M-1.2%	$3.5M-21.4%	$3.5M-15.3%	$1.5M-74.8%	$5.6M-16.6%	$4.5M-25.1%	$4.2M-37.3%
SG&A Expenses	$1.7M-34.2%	$2.0M-35.3%	$2.1M-37.0%	$2.4M-28.3%	$2.7M-22.3%	$3.2M-6.8%	$3.4M-6.9%	$3.3M-15.5%
Operating Income	-$2.1M+49.4%	-$7.5M+13.4%	-$5.6M+27.7%	-$5.9M+20.7%	-$4.1M+55.8%	-$8.7M+12.8%	-$7.8M+18.1%	-$7.4M+28.5%
EBITDA	-$1.7M+53.5%	-$7.1M+13.4%	-$5.3M+28.6%	-$5.5M+21.0%	-$3.7M+58.2%	-$8.2M+12.9%	-$7.4M+18.6%	-$7.0M+29.5%
Interest Expense	$791K+30.1%	$746K+44.6%	$649K-36.5%	$679K-47.0%	$608K-51.1%	$516K-57.0%	$1.0M-14.0%	$1.3M+16.1%
Income Tax	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	-$8.1M-977.4%	-$9.2M+31.9%	-$8.8M-9.9%	-$7.4M-9.3%	-$751K+93.2%	-$13.5M-33.2%	-$8.0M-230.3%	-$6.8M+73.0%
EPS (Basic)	-$0.69-666.7%	N/A	-$0.85+30.3%	-$0.78+26.4%	-$0.09+94.8%	N/A	-$1.22-221.1%	-$1.06+81.8%

Not reported in any period shown, so not listed: EPS (Diluted), Diluted Shares (Avg).

CLNNW Balance Sheet

CLNNW quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19
Total Assets	$18.1M-33.7%	$27.3M-47.8%	$52.3M+17.6%	$44.5M-29.4%	$63.1M-7.6%	$68.2M+358.7%	$14.9M
Current Assets	$9.0M-44.4%	$16.2M-58.4%	$38.9M+33.1%	$29.2M-46.5%	$54.6M-13.3%	$63.0M+564.7%	$9.5M
Cash & Equivalents	$5.2M-57.3%	$12.2M-57.8%	$28.8M+57.2%	$18.3M-63.5%	$50.3M-15.2%	$59.3M+574.5%	$8.8M
Inventory	$37K-45.6%	$68K+83.8%	$37K-14.0%	$43K+4.9%	$41K-78.5%	$191K+582.1%	$28K
Accounts Receivable	$0-100.0%	$64K-55.2%	$143K-24.3%	$189K+285.7%	$49K+133.3%	$21K	N/A
Total Liabilities	$35.7M-1.3%	$36.2M-7.1%	$39.0M-5.6%	$41.3M-18.2%	$50.5M-25.7%	$67.9M-17.8%	$82.7M
Current Liabilities	$10.8M+4.7%	$10.3M-59.4%	$25.3M+82.8%	$13.9M+130.0%	$6.0M-48.4%	$11.7M+170.5%	$4.3M
Non-Current Liabilities	$24.9M-3.7%	$25.9M+90.2%	$13.6M-50.3%	$27.4M-38.3%	$44.4M-21.0%	$56.2M-28.2%	$78.3M
Long-Term Debt	$17.8M	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$17.6M-98.6%	-$8.9M-166.1%	$13.4M+313.7%	$3.2M-74.3%	$12.6M+3594.1%	$341K+100.5%	-$67.8M
Retained Earnings	-$308.3M-9.3%	-$282.1M-16.2%	-$242.7M-25.6%	-$193.2M-18.3%	-$163.3M-6.3%	-$153.6M-120.7%	-$69.6M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$21.7M-14.4%	$18.1M-33.7%	$22.3M-29.3%	$22.1M-45.1%	$25.3M-43.8%	$27.3M-47.8%	$31.6M-47.8%	$40.3M-40.6%
Current Assets	$13.0M-11.2%	$9.0M-44.4%	$12.7M-35.7%	$12.0M-57.1%	$14.7M-54.3%	$16.2M-58.4%	$19.7M-57.6%	$27.9M-47.7%
Cash & Equivalents	$5.9M-39.6%	$5.2M-57.3%	$7.9M-45.9%	$7.3M-66.4%	$9.8M-54.8%	$12.2M-57.8%	$14.6M-65.2%	$21.7M-56.0%
Inventory	$54K+42.1%	$37K-45.6%	$61K-52.3%	$79K+113.5%	$38K+2.7%	$68K+83.8%	$128K+23.1%	$37K-28.8%
Accounts Receivable	N/A	$0-100.0%	$0	$0	$0-100.0%	$64K-55.2%	$0-100.0%	$0-100.0%
Total Liabilities	$40.5M+33.6%	$35.7M-1.3%	$34.7M-2.9%	$30.7M-24.9%	$30.3M-25.8%	$36.2M-7.1%	$35.7M-8.5%	$40.8M-11.8%
Current Liabilities	$6.7M-37.5%	$10.8M+4.7%	$8.3M-65.1%	$7.6M-73.0%	$10.8M-58.9%	$10.3M-59.4%	$23.8M+56.1%	$28.1M+389.4%
Non-Current Liabilities	$33.7M+72.8%	$24.9M-3.7%	$26.4M+122.2%	$23.1M+81.0%	$19.5M+33.5%	$25.9M+90.2%	$11.9M-50.1%	$12.8M-68.5%
Long-Term Debt	$17.7M+6.4%	$17.8M	$17.9M	$16.5M	$16.6M	N/A	N/A	N/A
Total Equity	-$18.8M-278.2%	-$17.6M-98.6%	-$12.4M-199.6%	-$8.6M-1596.4%	-$5.0M-216.6%	-$8.9M-166.1%	-$4.1M-119.3%	-$504K-102.3%
Retained Earnings	-$316.4M-11.8%	-$308.3M-9.3%	-$299.1M-11.4%	-$290.3M-11.4%	-$282.9M-11.5%	-$282.1M-16.2%	-$268.6M-15.5%	-$260.6M-13.2%

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Goodwill.

CLNNW Cash Flow Statement

CLNNW quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$18.1M	-$18.5M+13.0%	-$21.3M+29.3%	-$30.2M+22.7%	-$39.0M-12.7%	-$34.6M-82.9%	-$18.9M-43.4%	-$13.2M
Depreciation & Amortization	N/A	$1.5M-12.8%	$1.7M-5.7%	$1.8M+65.0%	$1.1M+6.2%	$1.0M-8.9%	$1.1M+10.5%	$1.0M
Stock-Based Compensation	N/A	$6.4M-19.8%	$8.0M-12.8%	$9.1M+7.1%	$8.5M-31.3%	$12.4M+1527.3%	$761K+90.7%	$399K
Capital Expenditures	N/A	$39K+160.0%	$15K-95.5%	$330K-93.6%	$5.2M+288.8%	$1.3M+244.2%	$387K+31.6%	$294K
Free Cash Flow	N/A	-$18.6M+12.9%	-$21.3M+30.0%	-$30.5M+31.0%	-$44.2M-22.9%	-$36.0M-86.1%	-$19.3M-43.2%	-$13.5M
Investing Cash Flow	-$39K	-$39K-100.6%	$6.3M+521.3%	-$1.5M+85.3%	-$10.2M-663.1%	-$1.3M-244.2%	-$387K-31.6%	-$294K
Financing Cash Flow	$14.1M	$11.5M+853.3%	-$1.5M-103.6%	$42.2M+144.4%	$17.2M-36.4%	$27.1M-61.0%	$69.5M+1163.6%	$5.5M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	-$4.5M+9.6%	-$4.8M+1.4%	-$4.0M-32.1%	-$4.7M+25.4%	-$5.0M+29.2%	-$4.9M+32.2%	-$3.0M+55.3%	-$6.4M+9.5%
Depreciation & Amortization	$355K-12.1%	$360K-13.7%	$365K-12.7%	$366K-15.3%	$404K-9.6%	$417K-12.6%	$418K-8.1%	$432K-6.7%
Stock-Based Compensation	$1.3M-32.6%	N/A	$1.7M-22.2%	$1.4M-29.9%	$1.9M-3.3%	N/A	$2.2M-8.7%	$2.0M-20.4%
Capital Expenditures	N/A	$28K+2700.0%	$11K+1000.0%	$0-100.0%	$0-100.0%	$1K-97.7%	$1K-97.9%	$2K-94.9%
Free Cash Flow	N/A	-$4.8M+0.8%	-$4.0M-32.4%	-$4.7M+25.4%	-$5.0M+29.4%	-$4.9M+32.6%	-$3.0M+55.6%	-$6.4M+9.9%
Investing Cash Flow	$0	-$28K-1300.0%	-$11K-1000.0%	$0-100.0%	$0-100.0%	-$2K+100.0%	-$1K+97.9%	$6.2M+15920.5%
Financing Cash Flow	$5.2M+95.8%	$2.1M-18.1%	$4.6M+214.2%	$2.1M+7517.9%	$2.7M+14168.4%	$2.5M+14144.4%	-$4.1M-1615.6%	$28K-99.9%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

CLNNW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CLNNW quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19
Gross Margin	78.5%-1.0pp	79.5%-2.0pp	81.5%-13.0pp	94.5%+34.5pp	60.0%	N/A	N/A
Operating Margin	-11541.5%	-9676.3%	-6198.8%	-10234.5%	-6912.6%	-9812.6%	N/A
Net Margin	-13086.5%	-11520.5%	-7569.4%	-6325.2%	-1347.2%	-9357.8%	N/A
Return on Equity	N/A	N/A	-369.7%+554.5pp	-924.3%-846.9pp	-77.3%+5575.8pp	-5653.1%	N/A
Return on Assets	-144.3%-0.2pp	-144.1%-49.6pp	-94.6%-27.3pp	-67.2%-51.8pp	-15.4%+12.8pp	-28.2%+80.3pp	-108.6%
Current Ratio	0.83-0.7x	1.570.0x	1.53-0.6x	2.11-7.0x	9.06+3.7x	5.40+3.2x	2.20
Debt-to-Equity	N/A	N/A	2.91-9.8x	12.75+8.7x	4.01-195.1x	199.13	N/A
Asset Turnover	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.00	N/A
FCF Margin	-9292.5%	-6240.1%	-4663.8%	-9342.5%	-4973.2%	-9376.7%	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Gross Margin	100.0%+24.7pp	70.1%-10.1pp	100.0%+20.7pp	100.0%+19.8pp	75.3%-2.8pp	80.2%+2.6pp	79.3%-9.6pp	80.2%+4.8pp
Operating Margin	-13740.0%	-9733.8%	-37653.3%	-21718.5%	-5032.1%	-9511.0%	-8982.8%	-8122.0%
Net Margin	-53940.0%	-11981.8%	-58513.3%	-27477.8%	-927.2%	-14889.0%	-9179.3%	-7456.0%
Return on Assets	-37.4%-34.4pp	-50.9%-1.3pp	-39.3%-14.0pp	-33.5%-16.7pp	-3.0%+21.6pp	-49.6%-30.1pp	-25.3%-21.3pp	-16.8%+20.2pp
Current Ratio	1.94+0.6x	0.83-0.7x	1.53+0.7x	1.58+0.6x	1.36+0.1x	1.570.0x	0.83-2.2x	0.99-8.3x
Asset Turnover	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x
FCF Margin	N/A	-6268.8%	-26686.7%	-17570.4%	-6186.4%	-5347.3%	-3475.9%	-6986.8%

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$17.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.83), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Where Clene Inc. Warrant Ranks

Frequently Asked Questions

What is Clene Inc. Warrant's annual revenue?

Clene Inc. Warrant (CLNNW) reported $200K in total revenue for fiscal year 2025. This represents a -41.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Clene Inc. Warrant's revenue growing?

Clene Inc. Warrant (CLNNW) revenue declined by 41.5% year-over-year, from $342K to $200K in fiscal year 2025.

Is Clene Inc. Warrant profitable?

No, Clene Inc. Warrant (CLNNW) reported a net income of -$26.2M in fiscal year 2025.

What is Clene Inc. Warrant's EBITDA?

Clene Inc. Warrant (CLNNW) had EBITDA of -$21.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Clene Inc. Warrant have?

As of fiscal year 2025, Clene Inc. Warrant (CLNNW) had $5.2M in cash and equivalents against $17.8M in long-term debt.

What is Clene Inc. Warrant's gross margin?

Clene Inc. Warrant (CLNNW) had a gross margin of 78.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Clene Inc. Warrant's free cash flow?

Clene Inc. Warrant (CLNNW) recorded an outflow of $18.6M in free cash flow during fiscal year 2025. This represents a 12.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Clene Inc. Warrant's operating cash flow?

Clene Inc. Warrant (CLNNW) recorded an outflow of $18.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Clene Inc. Warrant's total assets?

Clene Inc. Warrant (CLNNW) had $18.1M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Clene Inc. Warrant's capital expenditures?

Clene Inc. Warrant (CLNNW) invested $39K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Clene Inc. Warrant spend on research and development?

Clene Inc. Warrant (CLNNW) invested $14.0M in research and development during fiscal year 2025.

How many shares does Clene Inc. Warrant have outstanding?

Clene Inc. Warrant (CLNNW) had 11M shares outstanding as of fiscal year 2025.

What is Clene Inc. Warrant's current ratio?

Clene Inc. Warrant (CLNNW) had a current ratio of 0.83 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Clene Inc. Warrant's return on assets (ROA)?

Clene Inc. Warrant (CLNNW) had a return on assets of -144.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is Clene Inc. Warrant's debt-to-equity ratio negative or not reported?

Clene Inc. Warrant (CLNNW) has negative shareholder equity of -$17.6M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Clene Inc. Warrant's Piotroski F-Score?

Clene Inc. Warrant (CLNNW) has a Piotroski F-Score of 1 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Clene Inc. Warrant's earnings high quality?

Clene Inc. Warrant (CLNNW) reported a net loss of $26.2M while operations used $18.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Clene Inc. Warrant cover its interest payments?

Clene Inc. Warrant (CLNNW) reported an operating loss of $23.1M against $2.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.